Pharmalink Consulting is categorized under Drugs, Proprietaries, and Sundries in Washington, DC .
Pharmalink Consulting was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 5416140 by the NAICS.
If you are seeking more information, feel free to contact Oliver Stephens at the company’s branch by writing to 20 F St Nw, Washington, District of Columbia DC 20001 or by phoning (800) 434-5808. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pharmalink Consulting |
Contact Person: | Oliver Stephens |
Address: | 20 F St Nw, Washington, District of Columbia 20001 |
Phone Number: | (800) 434-5808 |
Website Address: | pharmalinkconsulting.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Drugs, Proprietaries, and Sundries |
SIC Code: | 5122 |
NAICS Code: | 5416140 |
Share This Business: |
Pharmalink Consulting was started in 0 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 5416140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Oliver Stephens for inquiries that concern Pharmalink Consulting by calling the company number (800) 434-5808, as your correspondence is most welcome. Additionally, the physical location of the branch of Pharmalink Consulting can be found at the coordinates 38.89728,-77.01001 as well as the street address 20 F St Nw in Washington, District of Columbia 20001.
For its online presence, you may visit Pharmalink Consulting’s website at pharmalinkconsulting.com and engage with its social media outlets through on Twitter and on Facebook.